Bormioli Pharma SpA

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
EUR350.0005May-28Sr. SecuredB3B-BFloating3mEu3mEu+525-5503mEu+550 a-3mEu+550-95.50000
Tranche Comments
5 yr: First Pay: 2023-08-15; Redemption: 2027-08-15; Registration: 144A/Reg S; Comments: EUR350m 5NC1 SSN FRN RegS/144A. B3/B-/B. GloCos/ phy BRs: BNPP/GS(B&D), JBs: CA-CIB/IMI. IPTs E+525-550/ 0% floor/ 95 OID. Talk E+550 / 0% floor / 95.50 area (+/-0.25). Final 3mE+550 at 95.5. FTT: 5:15pm. MWC: Prior to 15 MAY 2024 at 100%+ applicable premium. CoC: 101%. LEI: 8156005FA529B177B435;
Use of Proceeds
Repay outstanding debt
CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
WNC860.0008Nov-20Bh. BipshinS2M-Gjjfyerl3sEm-3rEc+350-3753503fJu+350-479.00000
Tranche Comments
7 ik: Registration: 144L/Bpc S; Comments: LJR280y 7ZX1mh inh iiw KRZ. 144Y/RiwR. X2/X. XR(X&U)/XZQQ/Jnb/GDG. Ynjih Lyh h/i Xwj 31 - Zov 3 - 3hm wqlm. Lilj L+350/375 (0% nlooh), ij wih. Xiyi L+350;
Use of Proceeds
B&D

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research